Modalis Therapeutics Corporation (TYO:4883)
34.00
+1.00 (3.03%)
Jul 21, 2026, 1:16 PM JST
Modalis Therapeutics Employees
Modalis Therapeutics had 17 employees as of December 31, 2025. The number of employees increased by 3 or 21.43% compared to the previous year.
Employees
17
Change (1Y)
3
Growth (1Y)
21.43%
Revenue / Employee
n/a
Profits / Employee
-107.31M JPY
Market Cap
3.18B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 17 | 3 | 21.43% |
| Dec 31, 2024 | 14 | -23 | -62.16% |
| Dec 31, 2023 | 37 | 1 | 2.78% |
| Dec 31, 2022 | 36 | 10 | 38.46% |
| Dec 31, 2021 | 26 | 6 | 30.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Nippon Chemiphar | 878 |
| Pharma Foods International | 613 |
| WDB coco | 516 |
| Morishita Jintan | 359 |
| Taiko Pharmaceutical | 220 |
| Mizuho Medy | 193 |
| Cyfuse Biomedical K.K. | 23 |
| Solasia Pharma K.K. | 22 |
Modalis Therapeutics News
- 1 year ago - SOLVE FSHD and Modalis Announce Strategic Collaboration to Develop an Innovative CRISPR-Based Epigenome Editing Treatment for Facioscapulohumeral Muscular Dystrophy - Financial Post